281 related articles for article (PubMed ID: 20079693)
1. SUMO--a post-translational modification with therapeutic potential?
Woo CH; Abe J
Curr Opin Pharmacol; 2010 Apr; 10(2):146-55. PubMed ID: 20079693
[TBL] [Abstract][Full Text] [Related]
2. SUMO proteins in the cardiovascular system: friend or foe?
Shetty PMV; Rangrez AY; Frey N
J Biomed Sci; 2020 Oct; 27(1):98. PubMed ID: 33099299
[TBL] [Abstract][Full Text] [Related]
3. Coordination of Cellular Localization-Dependent Effects of Sumoylation in Regulating Cardiovascular and Neurological Diseases.
Abe JI; Sandhu UG; Hoang NM; Thangam M; Quintana-Quezada RA; Fujiwara K; Le NT
Adv Exp Med Biol; 2017; 963():337-358. PubMed ID: 28197922
[TBL] [Abstract][Full Text] [Related]
4. SUMO: From Bench to Bedside.
Chang HM; Yeh ETH
Physiol Rev; 2020 Oct; 100(4):1599-1619. PubMed ID: 32666886
[TBL] [Abstract][Full Text] [Related]
5. Potential Role of SUMO and SUMOylation in the Pathogenesis of Diabetes Mellitus.
Sadeghi M; Dehnavi S; Shohan M; Jamialahmadi T; Sathyapalan T; Sahebkar A
Curr Med Chem; 2023; 30(14):1623-1637. PubMed ID: 35980066
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms, regulation and consequences of protein SUMOylation.
Wilkinson KA; Henley JM
Biochem J; 2010 May; 428(2):133-45. PubMed ID: 20462400
[TBL] [Abstract][Full Text] [Related]
7. The post-translational modification, SUMOylation, and cancer (Review).
Han ZJ; Feng YH; Gu BH; Li YM; Chen H
Int J Oncol; 2018 Apr; 52(4):1081-1094. PubMed ID: 29484374
[TBL] [Abstract][Full Text] [Related]
8. Small-molecule inhibitors targeting small ubiquitin-like modifier pathway for the treatment of cancers and other diseases.
Hua D; Wu X
Eur J Med Chem; 2022 Apr; 233():114227. PubMed ID: 35247754
[TBL] [Abstract][Full Text] [Related]
9. Targeting SUMOylation cascade for diabetes management.
Sireesh D; Bhakkiyalakshmi E; Ramkumar KM; Rathinakumar S; Jennifer PS; Rajaguru P; Paulmurugan R
Curr Drug Targets; 2014; 15(12):1094-106. PubMed ID: 25230117
[TBL] [Abstract][Full Text] [Related]
10. De-SUMOylation enzyme of sentrin/SUMO-specific protease 2 regulates disturbed flow-induced SUMOylation of ERK5 and p53 that leads to endothelial dysfunction and atherosclerosis.
Heo KS; Chang E; Le NT; Cushman H; Yeh ET; Fujiwara K; Abe J
Circ Res; 2013 Mar; 112(6):911-23. PubMed ID: 23381569
[TBL] [Abstract][Full Text] [Related]
11. Paradoxes of Cellular SUMOylation Regulation: A Role of Biomolecular Condensates?
Cheng X; Yang W; Lin W; Mei F
Pharmacol Rev; 2023 Sep; 75(5):979-1006. PubMed ID: 37137717
[TBL] [Abstract][Full Text] [Related]
12. Progress in the Discovery of Small Molecule Modulators of DeSUMOylation.
Chen S; Dong D; Xin W; Zhou H
Curr Issues Mol Biol; 2020; 35():17-34. PubMed ID: 31422931
[TBL] [Abstract][Full Text] [Related]
13. Roles for SUMO modification during senescence.
Andreou AM; Tavernarakis N
Adv Exp Med Biol; 2010; 694():160-71. PubMed ID: 20886763
[TBL] [Abstract][Full Text] [Related]
14. SUMOylation in atherosclerosis.
Liu YZ; Xiao X; Hu CT; Dai Y; Qu SL; Huang L; Zhang C
Clin Chim Acta; 2020 Sep; 508():228-233. PubMed ID: 32439557
[TBL] [Abstract][Full Text] [Related]
15. Protein SUMOylation in neuropathological conditions.
Anderson DB; Wilkinson KA; Henley JM
Drug News Perspect; 2009 Jun; 22(5):255-65. PubMed ID: 19609463
[TBL] [Abstract][Full Text] [Related]
16. [Advances on SUMO substrates in Arabidopsis].
Guo MX; Fu YF
Yi Chuan; 2013 Jun; 35(6):727-34. PubMed ID: 23774017
[TBL] [Abstract][Full Text] [Related]
17. The function of SUMOylation and its crucial roles in the development of neurological diseases.
Chen X; Zhang Y; Wang Q; Qin Y; Yang X; Xing Z; Shen Y; Wu H; Qi Y
FASEB J; 2021 Apr; 35(4):e21510. PubMed ID: 33710677
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of the SUMOylation pathway in Drosophila.
Talamillo A; Sánchez J; Barrio R
Biochem Soc Trans; 2008 Oct; 36(Pt 5):868-73. PubMed ID: 18793153
[TBL] [Abstract][Full Text] [Related]
19. Deciphering the SUMO code in the kidney.
Yang Z; Zhang Y; Sun S
J Cell Mol Med; 2019 Feb; 23(2):711-719. PubMed ID: 30506859
[TBL] [Abstract][Full Text] [Related]
20. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
